Ling Li

Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion

Rui Su, Lei Dong, Yangchan Li et al. · Cancer Cell · 2020 · 742 citations · Full text

Immune Evasion, Medicine, Stem Cell Mobilization +8

Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib

Ling Li, Lisheng Wang, Liang Li et al. · Cancer Cell · 2012 · 414 citations · Full text

Tumor Biology, Cell Regulation, Medicine +9

The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth

Julie Secombe, Ling Li, Leni Sue Carlos et al. · Genes & Development · 2007 · 289 citations · Full text

SIRT1 Activation by a c-MYC Oncogenic Network Promotes the Maintenance and Drug Resistance of Human FLT3-ITD Acute Myeloid Leukemia Stem Cells

Ling Li, Tereza Osdal, YinWei Ho et al. · Cell stem cell · 2014 · 239 citations · Full text

Health Sciences, Medicine, Sirt1 Activation +8

Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Yu‐Pei Chen, Xu Liu, Qin Zhou et al. · The Lancet · 2021 · 217 citations

Oncology, Advanced Nasopharyngeal Carcinoma, Metronomic Therapy +9